The Manufacturers Life Insurance Company Makes New $351.72 Million Investment in Celestica, Inc. $CLS

The Manufacturers Life Insurance Company bought a new position in shares of Celestica, Inc. (NYSE:CLS) (TSE:CLS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 965,950 shares of the technology company’s stock, valued at approximately $351,717,000. The Manufacturers Life Insurance Company owned approximately 0.84% of Celestica as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Celestica during the fourth quarter worth about $28,000. Swiss RE Ltd. bought a new stake in Celestica in the 4th quarter valued at about $29,000. Cullen Frost Bankers Inc. bought a new stake in Celestica in the 4th quarter valued at about $30,000. Sittner & Nelson LLC acquired a new position in shares of Celestica during the 4th quarter worth approximately $31,000. Finally, Ascentis Independent Advisors acquired a new position in shares of Celestica during the 1st quarter worth approximately $29,000. Institutional investors own 67.38% of the company’s stock.

Wall Street Analysts Forecast Growth

CLS has been the subject of a number of analyst reports. UBS Group upgraded shares of Celestica from a “neutral” rating to a “buy” rating and lifted their price target for the company from $410.00 to $430.00 in a research report on Monday. Royal Bank Of Canada increased their price target on Celestica from $440.00 to $450.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 29th. TD Securities upgraded Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective on the stock in a research note on Wednesday, April 29th. Rothschild & Co Redburn began coverage on Celestica in a report on Friday, May 1st. They issued a “buy” rating and a $460.00 price objective for the company. Finally, Canadian Imperial Bank of Commerce upped their target price on Celestica from $480.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $439.81.

Celestica Price Performance

Shares of NYSE:CLS opened at $294.40 on Tuesday. The firm has a 50 day moving average of $338.98 and a 200-day moving average of $335.49. Celestica, Inc. has a 12 month low of $183.66 and a 12 month high of $474.02. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $33.85 billion, a PE ratio of 30.60 and a beta of 2.06.

Celestica (NYSE:CLS) (TSE:CLS) last posted its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.29 by $0.25. The business had revenue of $4.68 billion for the quarter, compared to analyst estimates of $4.30 billion. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The firm’s revenue for the quarter was up 62.4% on a year-over-year basis. During the same quarter last year, the business posted $1.39 EPS. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, equities research analysts predict that Celestica, Inc. will post 10.15 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Robert Mionis sold 23,496 shares of Celestica stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $362.39, for a total value of $8,514,715.44. Following the transaction, the chief executive officer owned 23,396 shares in the company, valued at approximately $8,478,476.44. This trade represents a 50.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Mandeep Chawla sold 16,117 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total value of $5,952,330.44. Following the transaction, the chief financial officer directly owned 65,444 shares of the company’s stock, valued at $24,169,778.08. This trade represents a 19.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 356,553 shares of company stock worth $135,238,444. Company insiders own 1.10% of the company’s stock.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.